Validity of image-defined risk factors in localized neuroblastoma: A report from two centers in Western Japan

J Pediatr Surg. 2015 Dec;50(12):2102-6. doi: 10.1016/j.jpedsurg.2015.08.039. Epub 2015 Aug 28.

Abstract

Background: Japanese Neuroblastoma Study Group (JNBSG) has been employing image-defined risk factors (IDRFs) since 2010. However, the report from INRG in 2011 supplemented description stating that isolated contact is considered to be IDRF-positive only in renal vessels. The aim of this study was to evaluate the validity of IDRFs by comparing the previous (PG) and new guidelines (NG).

Methods: IDRFs of patients with localized neuroblastoma treated at two centers in Western Japan from 2002 to 2013 were retrospectively reviewed by radiologists.

Results: 47 neuroblastomas (abdomen 38, pelvis 2, mediastinum 7) were evaluated. For abdominal neuroblastomas, IDRFs were present in 15/38 (39.5%) using PG and in 31/38 (81.6%) using NG. Moreover, the IDRF-positive rate increased from 26.7% (4/15) to 80.0% (12/15) in 15 cases diagnosed during mass screening. Of the IDRF-positive cases, complete primary resection was achieved in 2/15 (13.3%) using PG and 17/31 patients (54.8%) using NG. There were two major surgical renal complications in the IDRF-positive cases based on the use of either guidelines, and the specificity decreased from 64% to 19%.

Conclusions: According to NG, the IDRF-positive rate increased, and the resection rate decreased. NG may overestimate surgical risks, leading to unnecessary chemotherapy and a prolonged hospital stay.

Keywords: IDRFs; INRG; JNBSG; Neuroblastoma; renal complication; surgery.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Neoplasms / pathology
  • Abdominal Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Japan
  • Magnetic Resonance Imaging
  • Male
  • Mediastinal Neoplasms / pathology
  • Mediastinal Neoplasms / surgery
  • Neoplasm Staging
  • Neuroblastoma / pathology*
  • Neuroblastoma / surgery
  • Pelvic Neoplasms / pathology
  • Pelvic Neoplasms / surgery
  • Retrospective Studies
  • Risk Factors